Carl Goldfischer, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 675 shares at $5.50 ($4K) on 2007-08-10, disclosed to the SEC on 2007-08-14.
Open-market purchase of $4k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 11 | $61 | 1.6% |
| 2 | $5.50 | 664 | $4K | 98.4% |
| Total | $5.50 avg | 675 | $4K | 100% |
| Filing → |
| CBAY | SELL | 2018-03-23 | $195K | — | Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |